文献速递血液净化与透析

维持性血液透析患者的终末期撤透析与姑息治疗利用情况

End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy.
PubMed 文献 · Clin J Am Soc Nephrol · 2018-07-19

该单中心观察性队列纳入2001年至2013年新入透析的1226例成人患者,死亡536例,其中262例(49%)在死亡前撤透析。撤透析主要因急性医学并发症(51%)或衰弱/衰竭(22%),撤透析后中位死亡时间7天。仅34%撤透析患者接受姑息治疗服务。

要点

  • 本队列撤透析率为49%,约为既往报道的两倍。
  • 撤透析后中位死亡时间7天,住院死亡比例低于未撤透析组。
  • 仅34%撤透析患者接受姑息治疗,姑息治疗利用不足。

核心结论

  • 本单中心研究中撤透析率为既往报道的两倍,急性并发症和衰弱是驱动因素,但姑息治疗服务仅少数患者使用。

研究设计与样本

  • 观察性队列研究,纳入美国中西部三级中心2001年1月至2013年11月新入血液透析的成人患者,死亡事件随访至2015年11月,共1226例,死亡536例。

主要发现

  • 536例死亡患者中262例(49%)撤透析;随机抽取10%(52/536)死亡通知表复核,撤透析灵敏度73%。
  • 撤透析决定多由患者(60%)或家属代理(33%)做出,原因主要为急性医学并发症(51%)或衰弱/衰竭(22%)。
  • 撤透析后中位死亡时间7天(四分位距4-11),撤透析组住院死亡34%低于未撤透析组46%(P=0.003)。
  • 撤透析患者中34%(90/262)接受姑息治疗服务。
  • 撤透析组姑息治疗咨询与更长透析时长(每增加1年OR 1.19,95%CI 1.10-1.3,P<0.001)、死亡前30天内住院(OR 5.78,95%CI 2.62-12.73,P<0.001)及住院死亡(OR 1.92,95%CI 1.13-3.27,P=0.02)相关。

临床怎么用

  • 对维持性血透患者应关注高龄、白人种族、脑血管病、近期住院等撤透析风险因素,及时评估姑息治疗需求。

局限性

  • 单中心研究,结果外推需谨慎;撤透析识别基于死亡通知表复核,灵敏度73%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Withdrawal from maintenance hemodialysis before death has become more common because of high disease and treatment burden. The study objective was to identify patient factors and examine the terminal course associated with hemodialysis withdrawal, and assess patterns of palliative care involvement before death among patients on maintenance hemodialysis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We designed an observational cohort study of adult patients on incident hemodialysis in a midwestern United States tertiary center, from January 2001 to November 2013, with death events through to November 2015. Logistic regression models evaluated associations between patient characteristics and withdrawal status and palliative care service utilization. RESULTS: Among 1226 patients, 536 died and 262 (49% of 536) withdrew. A random sample (10%; 52 out of 536) review of Death Notification Forms revealed 73% sensitivity for withdrawal. Risk factors for withdrawal before death included older age, white race, palliative care consultation within 6 months, hospitalization within 30 days, cerebrovascular disease, and no coronary artery disease. Most withdrawal decisions were made by patients (60%) or a family member (33%; surrogates). The majority withdrew either because of acute medical complications (51%) or failure to thrive/frailty (22%). After withdrawal, median time to death was 7 days (interquartile range, 4-11). In-hospital deaths were less common in the withdrawal group (34% versus 46% nonwithdrawal, P=0.003). A third (34%; 90 out of 262) of those that withdrew received palliative care services. Palliative care consultation in the withdrawal group was associated with longer hemodialysis duration (odds ratio, 1.19 per year; 95% confidence interval, 1.10 to 1.3; P<0.001), hospitalization within 30 days of death (odds ratio, 5.78; 95% confidence interval, 2.62 to 12.73; P<0.001), and death in hospital (odds ratio, 1.92; 95% confidence interval, 1.13 to 3.27; P=0.02). CONCLUSIONS: In this single-center study, the rate of hemodialysis withdrawals were twice the frequency previously described. Acute medical complications and frailty appeared to be driving factors. However, palliative care services were used in only a minority of patients.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Chen JC, Thorsteinsdottir B, Vaughan LE, et al. End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy. Clin J Am Soc Nephrol. 2018. PMID: 30026285. doi:10.2215/CJN.00590118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。